Navigation Links
Fabled 'Freshman 15' pound gain more often only 5, report researchers
Date:4/6/2008

The freshman 15 - the rapid weight gain believed to afflict many new college students when they begin school - appears to be a bit of an urban legend: a cautionary tale often told but not well substantiated.

Now a study of 36 freshmen at Auburn University - located in one of the states with the highest prevalence of obesity in the nation - reports an average gain of only 1.9 pounds during the first semester, with women gaining slightly more than men, and an average gain of only 4.8 pounds for the entire freshman year (with males gaining an average of 5.4 pounds and women gaining an average of 3.2 pounds). Some students lost weight. But even when only those who gained were considered, the average weight gain was 5.8 pounds, a long way from the often-popularized 15.

Dr. Sareen Gropper presented the study at the Experimental Biology 2008 meeting in San Diego on Sunday, April 6. The presentation is part of the scientific program of the American Society for Nutrition.

The 36 freshman (26 females and 10 males) were weighed and their body composition and shape measured when they began college and then again at the end of the fall semester and the end of the spring semester. The urban legend is correct in the sense that a majority of freshmen in the study (71.4 percent) did gain weight, notes Dr. Gropper, but only 21 percent gained five pounds or more. The largest gainers in the fall semester were a woman who gained nine pounds and a male who gained 10 pounds. For the academic year, the largest weight gains observed were 13 pounds for one male and 12 pounds for one female. No one gained the freshman 15.

Dr. Gropper and colleagues have begun a larger study of 240 students who entered Auburn in the fall semester of 2007. Like the pilot study, participants had to be between 17 and 19 years of age, not married, having no children, and without diagnosed eating disorders. At the end of the first semester, 68.7 percent of students had ga
'/>"/>

Contact: Sylvia Wrobel
ebpress@gmail.com
770-722-1055
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Freshman class sparks start-up company
2. UDs Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals
3. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
4. Protein protects brain against compound in lead poisoning, liver disease
5. New form of compound stimulates research on hydrogen storage
6. Natural compound in broccoli could treat devastating genetic skin disorder
7. Synthetic compound promotes death of lung-cancer cells, tumors
8. Chemical compound present in detergents produce bacteria alterations in agricultural soils
9. Naturally-occurring apple compounds reduce risk of pancreatic cancer
10. New microsensor measures volatile organic compounds in water and air on-site
11. New research suggests biofuel blending is often inaccurate
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4